Ganga Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Ganga Pharmaceuticals has a total shareholder equity of ₹70.8M and total debt of ₹15.6M, which brings its debt-to-equity ratio to 22.1%. Its total assets and total liabilities are ₹90.1M and ₹19.3M respectively.
Key information
22.1%
Debt to equity ratio
₹15.62m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹4.77m |
| Equity | ₹70.77m |
| Total liabilities | ₹19.35m |
| Total assets | ₹90.11m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 539680's short term assets (₹69.7M) exceed its short term liabilities (₹14.2M).
Long Term Liabilities: 539680's short term assets (₹69.7M) exceed its long term liabilities (₹5.2M).
Debt to Equity History and Analysis
Debt Level: 539680's net debt to equity ratio (15.3%) is considered satisfactory.
Reducing Debt: 539680's debt to equity ratio has reduced from 33.6% to 22.1% over the past 5 years.
Debt Coverage: 539680's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 539680's interest payments on its debt are well covered by EBIT.